Connection

Aldo Maggioni to Rivaroxaban

Back to Details
This is a "connection" page, showing publications Aldo Maggioni has written about Rivaroxaban.
Aldo Maggioni
Connection Strength
0.892
Rivaroxaban
  1. Stroke prevention by low-dose anticoagulation in patients with heart failure and sinus rhythm: is it worth the effort? Eur Heart J. 2019 11 21; 40(44):3602-3604.
    View in: PubMed
    Score: 0.149
  2. Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis. Circulation. 2019 10 29; 140(18):1451-1459.
    View in: PubMed
    Score: 0.148
  3. Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease. Circulation. 2019 08 13; 140(7):529-537.
    View in: PubMed
    Score: 0.145
  4. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. Gastroenterology. 2019 09; 157(3):682-691.e2.
    View in: PubMed
    Score: 0.145
  5. Stroke Outcomes in the COMPASS Trial. Circulation. 2019 02 26; 139(9):1134-1145.
    View in: PubMed
    Score: 0.142
  6. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med. 2017 10 05; 377(14):1319-1330.
    View in: PubMed
    Score: 0.128
  7. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology. 2019 08; 157(2):403-412.e5.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.